Jim Hawkins Joins myoscience Board of Directors

Jim Hawkins Joins myoscience Board of Directors

REDWOOD CITY, Calif., Dec. 3, 2013 (GLOBE NEWSWIRE) -- California based
myoscience, inc., developers of the ioveraº[®] product powered by Focused Cold
Therapy^TM for the treatment of peripheral nerve conditions, announced today
Jim Hawkins has joined its Board of Directors.

"We are very fortunate to welcome Jim to our Board of Directors. Jim is an
experienced medical technology veteran who has built many successful
businesses," said Clint Carnell, Chairman and Chief Executive Officer of
myoscience. "Jim will be a valuable resource to the Company, and to me
personally, as we continue to grow and scale our business."

"I am delighted to join myoscienceand look forward to working closely with
the board and the management team to further the Company's achievements of its
innovative ioveraº system," said Jim Hawkins.Mr. Hawkins has served as Chief
Executive Officer and a member of the Board of Directors of Natus Medical
Incorporated (Nasdaq:BABY) since April 2004. In addition, he currently serves
as a director of Digirad Corporation and IRIDEX Corporation. Prior to joining
Natus, Mr. Hawkins was President, Chief Executive Officer and a Director of
Invivo Corporation, a developer and manufacturer of multi-parameter vital sign
monitoring equipment.

About myoscience

Silicon Valley, California-based myoscience is a privately-held medical device
company committed to making its platform technology, Focused Cold Therapy^TM,
the standard of care for the treatment of peripheral nerve conditions. Focused
Cold Therapy is the technology underlying the ioveraº treatment, which is
currently approved in Europe and Canada for temporary wrinkle reduction,
temporary pain reduction and treatment of dermatologic conditions. The
myoscience technology has also been cleared in the United States for use in
pain management and general surgical use. For more information, please visit
www.myoscience.com.

The myoscience logo is available at
http://www.globenewswire.com/newsroom/prs/?pkgid=13581

© 2013 myoscience. All rights reserved. ioveraº and Focused Cold Therapy are
trademarks of myoscience.


CONTACT: Peter Osborne
         650-474-2600
         posborne@myoscience.com

company logo